Study shows promise in repairing damaged myelin
A scientific breakthrough provides new hope for millions of people living with multiple sclerosis. Researchers at OHSU have developed a compound that stimulates repair of the protective sheath that covers nerve cells in the brain and spinal cord.
The discovery, involving mice genetically engineered to mimic multiple sclerosis, published today in the journal JCI Insight.
“There are no drugs available today that will re-myelinate the de-myelinated axons and nerve fibers, and ours does that,” said senior author Tom Scanlan, Ph.D., professor of physiology and pharmacology in the OHSU School of Medicine.
Pierre Moenne-Loccoz, PhD & Linda Susan Musil, PhD are promoted to full professor
Two basic science departments to join
SoM leverages expertise, technology and fresh investment to form new, expanded department
Dean Sharon Anderson approved a proposal to combine two basic science departments in the OHSU School of Medicine to form a new, expanded department starting July 1.
The Department of Biochemistry and Molecular Biology and the Department of Physiology and Pharmacology will join together to leverage faculty specialties and technology. Read more.
- Three Physiology and Pharmacology Students Receive 2018 Tartar Award
- Dr. Xiangshu Xiao Receives Funding to Develop a New Therapy for Drug-resistant Ovarian Cancer
- Estrogenic-Dependent Glutamatergic Neurotransmission from Kisspeptin Neurons Governs Feeding Circuit
- Acute Hyperalgesia and Delayed Dry Eye After Corneal Abrasion Injury
- Martin Kelly, Ph.D., Receives 2018 Biomedical Innovation Program Drug Discovery Award